# ZEVRA THERAPEUTICS, INC. (ZVRA) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from ZEVRA THERAPEUTICS, INC.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/ZVRA/mda/fy2025/): filed 2026-03-09; accession 0001434647-26-000011 (https://www.sec.gov/Archives/edgar/data/1434647/000143464726000011/zvra-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/ZVRA/mda/fy2024/): filed 2025-03-12; accession 0001437749-25-007320 (https://www.sec.gov/Archives/edgar/data/1434647/000143774925007320/zvra20241231_10k.htm)
- [FY 2023 MD&A](/company/ZVRA/mda/fy2023/): filed 2024-04-01; accession 0001437749-24-010430 (https://www.sec.gov/Archives/edgar/data/1434647/000143774924010430/zvra20231231_10k.htm)
- [FY 2022 MD&A](/company/ZVRA/mda/fy2022/): filed 2023-03-07; accession 0001437749-23-005703 (https://www.sec.gov/Archives/edgar/data/1434647/000143774923005703/kmph20221231_10k.htm)
- [FY 2021 MD&A](/company/ZVRA/mda/fy2021/): filed 2022-03-31; accession 0001437749-22-007725 (https://www.sec.gov/Archives/edgar/data/1434647/000143774922007725/kmph20211231_10k.htm)

Back to /company/ZVRA/